Denali Advisors LLC Novartis Ag Transaction History
Denali Advisors LLC
- $846 Million
- Q3 2025
A detailed history of Denali Advisors LLC transactions in Novartis Ag stock. As of the latest transaction made, Denali Advisors LLC holds 13,559 shares of NVS stock, worth $1.78 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
13,559
Previous 21,813
37.84%
Holding current value
$1.78 Million
Previous $2.64 Million
34.14%
% of portfolio
0.21%
Previous 0.28%
Shares
5 transactions
Others Institutions Holding NVS
# of Institutions
1,600Shares Held
137MCall Options Held
1.53MPut Options Held
2.22M-
Dodge & Cox San Francisco, CA10.6MShares$1.39 Billion0.78% of portfolio
-
Primecap Management CO Pasadena, CA9.34MShares$1.23 Billion0.95% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.84MShares$1.16 Billion0.25% of portfolio
-
Morgan Stanley New York, NY7.73MShares$1.02 Billion0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa7.24MShares$952 Million0.34% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $283B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...